Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05421013 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC
A Phase 1 study, sponsored by Sirnaomics.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT05421013 is a Phase 1 study that has completed, run by Sirnaomics. The registered enrollment target is 9 participants.
The verdict
NCT05421013, a Phase 1 study, has completed, sponsored by Sirnaomics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Open label, dose escalation to evaluate safety.
Interventions
- DRUG STP705
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2023-03-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05421013
The ClinicalTrials.gov registry entry for NCT05421013 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sirnaomics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which STP705 is the first listed.
NCT05421013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05421013 about?
NCT05421013 is a clinical study titled "Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC". Open label, dose escalation to evaluate safety.
What is the current status of trial NCT05421013?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2022-08-01. Estimated completion is 2023-03-29.
What interventions are being tested in trial NCT05421013?
The interventions under investigation include: STP705 (DRUG).
Who is sponsoring clinical trial NCT05421013?
This trial is sponsored by Sirnaomics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.